By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Universal Times MagazineUniversal Times MagazineUniversal Times Magazine
  • Home
  • Industries
    • Automobile
    • Aviation
    • Banking
    • Cryptocurrency
    • E- Commerce
    • EdTech
    • Energy and Petroleum
    • Fintech
    • FMCG
    • Information Technology
    • NBFC
    • Oil
    • Pharmacy
    • Telecom
    • Other Business News
  • Blogs
  • World
  • Jobs
  • Careers
  • About us
  • Privacy Policy
  • Contact
Search
Copyright © 2020-2024 Universal Times Magazine. All Rights Reserved.
Reading: SBI gets central board’s nod to raise Rs 14,000 crore via Basel-III compliant bonds
Share
Notification
Aa
Universal Times MagazineUniversal Times Magazine
Aa
  • Home
  • Industries
  • Blogs
  • World
  • Jobs
  • Careers
  • About us
  • Privacy Policy
  • Contact
Search
  • Home
  • Industries
    • Automobile
    • Aviation
    • Banking
    • Cryptocurrency
    • E- Commerce
    • EdTech
    • Energy and Petroleum
    • Fintech
    • FMCG
    • Information Technology
    • NBFC
    • Oil
    • Pharmacy
    • Telecom
    • Other Business News
  • Blogs
  • World
  • Jobs
  • Careers
  • About us
  • Privacy Policy
  • Contact
Follow US
  • Home
  • Industries
  • Blogs
  • World
  • Jobs
  • Careers
  • About us
  • Privacy Policy
  • Contact
Copyright © 2020-2024 Universal Times Magazine. All Rights Reserved.

Advertisement

Universal Times Magazine > Blog > Banking > SBI gets central board’s nod to raise Rs 14,000 crore via Basel-III compliant bonds
Banking

SBI gets central board’s nod to raise Rs 14,000 crore via Basel-III compliant bonds

Gaurav Verma
Last updated: 2021/06/22 at 11:12 AM
Gaurav Verma
Share
2 Min Read
SHARE

Advertisement

The country’s largest bank, State Bank of India, plans to raise upto Rs 14,000 crore through additional tier-I bonds (AT1 bonds) in current financial year (FY22) to enhance capital adequacy profile.

Contents
Regulatory filing read asFund Raised and RedeemPerformance

However, the Central Board approved the capital raise by way of issuance of Basel lll-compliant debt instruments.

The bonds are proposed to be raised in Indian or US currency.

Regulatory filing read as

“The central board of the bank at its meeting held today on June 21, 2021, accorded approval for raising capital by way of issuance of Basel III compliant debt instruments in USD and/or INR during FY22.”

Under this, the bank plans to raise fresh additional tier I capital up to an amount of Rs 14,000 crore subject to the government of India concurrence, it added.

Fund Raised and Redeem

During FY21, SBI mopped up ₹6,500 crore via Basel III compliant debt instruments under AT-1 and ₹20,931 crore via Tier – 2 capital, as per the bank’s annual report.

During FY21, the bank redeemed AT-1 Bonds aggregating to ₹200 crore and Tier-2 Bonds aggregating to ₹16,647.83 crore.

Performance

The capital adequacy position of the bank improved from 13.06 per cent in March last year to 13.74 per cent in March 2021.

The CET (Common Equity Tier) 1 capital and AT-1 capital ratios put together increased by 44 bps to 11.44 per cent.

The bank also increased its Tier-II capital base to 2.30 per cent in March 2021 from 2.06 per cent the previous year.

(with Inputs from Money Control)

Press the 🔔 icon for notifications of all new updates

Advertisement

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
[mc4wp_form]
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Gaurav Verma June 22, 2021 June 22, 2021
Share This Article
Facebook Twitter Whatsapp Whatsapp LinkedIn Copy Link
Share
Avatar
By Gaurav Verma
Follow:
Founder
Previous Article Indian Bank launched its QIP of Rs 4,000-crore; check details
Next Article E I DuPont recruiting B.COM/CPA for Finance Executive

Stay Connected

2.2k Followers Like
727 Followers Follow
25.7k Followers Follow
444 Subscribers Subscribe

Advertisement

Latest News

Advertisement

Follow US
Copyright © 2020-2025 Universal Times Magazine. All Rights Reserved.
adbanner
AdBlock Detected
Our site is an advertising supported site. Please whitelist to support our site.
Okay, I'll Whitelist
Welcome Back!

Sign in to your account

Lost your password?

Subscribe For Latest Updates

Sign up to best of business news, informed analysis and opinions on what matters to you.

Invalid email address
We promise not to spam you. You can unsubscribe at any time.
Thanks for subscribing!